{
  "name": "BioInvent International",
  "slug": "bioinvent-international",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-05T23:41:00Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-05: stängning 22.75, volym 69450",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/bioinvent-international/reports",
    "count": 16,
    "nasdaq_count": 16,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-04-29",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "BioInvent International AB: Delårsrapport januari - mars 2026",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=be158a6dd3920b5c915eb1cf51aaf26d9&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a765f877b02a605a235a412ef9ad999ae",
            "date": "2026-04-29",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "BioInvent_2026_Q1_SE.pdf",
            "text_chars": 52183,
            "sha256": "760646253561e826b991c899b5cef3cb5011cd352be5ea975efff2c17d64c8de",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 52183
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-03-31",
        "title": "Årsredovisning 2025",
        "original_title": "BioInvent International AB publicerar årsredovisningen för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b63c54630b6b77a174e8fb86a1012f0ba&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a487fe042126ce0a635def2e18fe5d002",
            "date": "2026-03-31",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "BioInvent_AR_2025_SE.pdf",
            "text_chars": 256078,
            "sha256": "efdccbf6e381225957a5e1d1ec52affbf07ebb50fb74e59db702d78f170bc384",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 179786
              },
              {
                "number": 2,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 76290
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-26",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "BioInvent International AB: Bokslutskommuniké 1 januari - 31 december 2025",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b63f1fa8542a4e536857a93ea14af0df4&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7d93f053ec21ea8d08e351a192d6fb13",
            "date": "2026-02-26",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "BioInvent_Q4_2025_SE_Final.pdf",
            "text_chars": 64011,
            "sha256": "2d2727acac874bdb56f04acbbf3713f8b0f0cd5c63ed787ec40a0efb43b0e2a1",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 64011
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-10-29",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "BioInvent International AB: Delårsrapport januari - september 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b758b8ef9cd3ea8cc78fd117758642c86&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aaf62030777dde1c77b31a87decc7bd13",
            "date": "2025-10-29",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "BioInvent_Q3_2025_SE.pdf",
            "text_chars": 62170,
            "sha256": "aa97c4a88aa00b4c59994f746f13afa80d91ae6f51ceda1f600b038aab6b10e4",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 62170
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-08-26",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "BioInvent International AB: Delårsrapport januari - juni 2025",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b5be98a3ef48295226895d8270ed14d8e&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad1e4a43e2a0a70f0f24a5ec5030dc63b",
            "date": "2025-08-26",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "BioInvent_Q2_2025_SE_25_Augusti.pdf",
            "text_chars": 58410,
            "sha256": "eeb118e6a4b98d146a147018439761cecf789891a2277744590fe9fb3634b4ce",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 58410
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-04-29",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "BioInvent International AB: Delårsrapport januari - mars 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b4ead05c5608663c73175af63f2171ab2&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a93fd97dcbb69c06a98bbca3d7915bb01",
            "date": "2025-04-29",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "BioInvent_Q1_2025_SE.pdf",
            "text_chars": 56957,
            "sha256": "1bde995565aefd97353a9ada785e5cca9fced64bec2afdf11882a57e3c20d3ba",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 56957
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-04-04",
        "title": "Årsredovisning 2024",
        "original_title": "BioInvent International AB publicerar årsredovisningen för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1b104722ee5caed8feac68349be1c315&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a81b8869e169747bb6eb2e0628e40d1c6",
            "date": "2025-04-04",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "BioInvent_AR_2024_SE_FINAL.pdf",
            "text_chars": 264240,
            "sha256": "01966b16031def74138efc849144ab9f45c904525300f2a9102c2b212247dd63",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 173839
              },
              {
                "number": 2,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 90399
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-27",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "BioInvent International AB: Bokslutskommuniké 1 januari - 31 december 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b4325ea86558e37754645d98a44d9fcb9&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4e46e0f8f95e50791a1efc8f5291065e",
            "date": "2025-02-27",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "BioInvent_Q4_2024_SE_Final.pdf",
            "text_chars": 63027,
            "sha256": "84f9d860cd29baa7e8faa628a471da8d32e7f31ae82dea8c5b947383677bad6d",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 63027
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-10-31",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "BioInvent International AB: Delårsrapport januari-september 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd4cfcd01dd2b8b94214bd849bb5735a4&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a6f0722ec763ee02c5204b7bb5397531e",
            "date": "2024-10-31",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "BioInvent_Q3_2024_SE_Final.pdf",
            "text_chars": 64135,
            "sha256": "240176b82d9e84f7441753a319c02de449d5a7332909d6f0c16bdc5b0dc6d422",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 64135
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-08-29",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "BioInvent International AB: Delårsrapport januari-juni 2024",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb820dcd84852a821843b4d764b9a506c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a8c9a195497c084357930d08809bd444d",
            "date": "2024-08-29",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "BioInvent_Q2_2024_SE_Final.pdf",
            "text_chars": 65072,
            "sha256": "d87a7337d230474edc9255512d8e54ec176e2ae3b84aa7701ad9a01665f29f65",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 65072
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-04-24",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "BioInvent International AB: Delårsrapport januari-mars 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b7f72929e5278ad28f6fadbf66ec061a8&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a02eeedd16b87572fea4fcf26b0036b83",
            "date": "2024-04-24",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "BioInvent_Q1_2024_SE_Final.pdf",
            "text_chars": 57224,
            "sha256": "2330486ede597bccc52644461b86760db9c1fe658e5b7f0be2699431033a1d77",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 57224
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-04-04",
        "title": "Årsredovisning 2023",
        "original_title": "BioInvent International AB publicerar Årsredovisning 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b5a27e4b656010db5805548be94869731&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a364100d8e3ca8d4be33a4e4eb14893b9",
            "date": "2024-04-04",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "BioInvent_AR_2023_SE.pdf",
            "text_chars": 253055,
            "sha256": "ed832cbeb1c10ece3a28450f47b49f338d8d1000b6e892991e84f7de368cbd3f",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 178243
              },
              {
                "number": 2,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 74810
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-22",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "BioInvent International AB Bokslutskommuniké 1 januari - 31 december 2023",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bcad389850ce081669e8db0814075b534&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2412234949072bf59eac8ed22b6f1633",
            "date": "2024-02-22",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "BioInvent_Q4_2023_SE_21_Februari.pdf",
            "text_chars": 59858,
            "sha256": "2d189019d4289cc37d2484e846ec7a2e9eb1432009e169b77e34fc954b2566e7",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 59858
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-10-26",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "BioInvent International AB: Delårsrapport januari-september 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=be3c96a549266656b51480317ea317825&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4d494801f274a18bac47cb87692323de",
            "date": "2023-10-26",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "BioInvent_Q3_2023_SE.pdf",
            "text_chars": 55909,
            "sha256": "f088a9b62e0de2fddf99459d82055070e218251219008656016d322dc900782e",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 55909
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-08-30",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "BioInvent International AB: Delårsrapport januari-juni 2023",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bf4bf34de03398ac4aa733181ca29a635&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2ca36c1ee58d29ec5d20efefaa15b8d0",
            "date": "2023-08-30",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "BioInvent_Q2_2023_SE_Final.pdf",
            "text_chars": 57056,
            "sha256": "266f99d8d9266ae077b85ffdfca158499eff19828176065eb8f8742e17c79dad",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 57056
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-04-26",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "BioInvent International AB: Delårsrapport januari-mars 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b66bfb93a046b6bf82a485c034c6d0a45&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/afbe6ff197068f6b7d4cbebf39b901af2",
            "date": "2023-04-26",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "BioInvent_Q1_2023_SE_Final.pdf",
            "text_chars": 53310,
            "sha256": "dd69154f612588fe8b682c646a8b90d596286f7c55ae6eb5c35ca0596f7bdbe9",
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 53310
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 16,
  "nasdaq_report_count": 16,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "BioInvent International",
    "identity": {
      "issuer": "BioInvent International Aktiebolag",
      "lei": "549300E7QRHEF2IJUY10",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 3,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "BioInvent International",
      "query": "BioInvent International Aktiebolag",
      "candidate_count": 346
    },
    "period": {
      "from": "2024-08-04",
      "to": "2026-08-04",
      "years": 2
    },
    "generated_at": "2026-08-04T09:01:33Z",
    "insider": {
      "transactions": 2,
      "all_export_rows": 2,
      "acquisitions": 0,
      "disposals": 0,
      "other": 2,
      "acquisition_value_sek": 0,
      "disposal_value_sek": 0,
      "characters": {
        "Teckning": 2
      }
    },
    "short_selling": {
      "aggregate_percent": 0.4,
      "current_public_positions": 0,
      "historical_changes": 0,
      "current_position_sum_over_0_5": 0
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "binv",
      "instrument_id": "TX351",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/binv?id=TX351"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "BioInvent International",
      "expected_name": "BioInvent International",
      "match_score": 100.0,
      "slug": "bioinvent-international",
      "url": "https://mfn.se/all/a/bioinvent-international",
      "metadata": {
        "country": "Sverige",
        "list": "Mid Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Bioteknik",
        "website": "https://career.modularfinance.se"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX351",
      "asset_class": "SHARES",
      "isin": "SE0015244520",
      "symbol": "BINV",
      "company": "BioInvent International",
      "market": null,
      "last_sale_price": "SEK 22.75",
      "time_as_of": "2026-08-05"
    },
    "finansinspektionen": {
      "issuer": "BioInvent International Aktiebolag",
      "lei": "549300E7QRHEF2IJUY10",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 3,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "BioInvent International",
      "query": "BioInvent International Aktiebolag",
      "candidate_count": 346
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a765f877b02a605a235a412ef9ad999ae",
      "date": "2026-04-29",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "BioInvent_2026_Q1_SE.pdf",
      "text_chars": 52183,
      "sha256": "760646253561e826b991c899b5cef3cb5011cd352be5ea975efff2c17d64c8de",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 52183
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a487fe042126ce0a635def2e18fe5d002",
      "date": "2026-03-31",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "BioInvent_AR_2025_SE.pdf",
      "text_chars": 256078,
      "sha256": "efdccbf6e381225957a5e1d1ec52affbf07ebb50fb74e59db702d78f170bc384",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 179786
        },
        {
          "number": 2,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 76290
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7d93f053ec21ea8d08e351a192d6fb13",
      "date": "2026-02-26",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "BioInvent_Q4_2025_SE_Final.pdf",
      "text_chars": 64011,
      "sha256": "2d2727acac874bdb56f04acbbf3713f8b0f0cd5c63ed787ec40a0efb43b0e2a1",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 64011
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aaf62030777dde1c77b31a87decc7bd13",
      "date": "2025-10-29",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "BioInvent_Q3_2025_SE.pdf",
      "text_chars": 62170,
      "sha256": "aa97c4a88aa00b4c59994f746f13afa80d91ae6f51ceda1f600b038aab6b10e4",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 62170
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad1e4a43e2a0a70f0f24a5ec5030dc63b",
      "date": "2025-08-26",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "BioInvent_Q2_2025_SE_25_Augusti.pdf",
      "text_chars": 58410,
      "sha256": "eeb118e6a4b98d146a147018439761cecf789891a2277744590fe9fb3634b4ce",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 58410
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a93fd97dcbb69c06a98bbca3d7915bb01",
      "date": "2025-04-29",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "BioInvent_Q1_2025_SE.pdf",
      "text_chars": 56957,
      "sha256": "1bde995565aefd97353a9ada785e5cca9fced64bec2afdf11882a57e3c20d3ba",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 56957
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a81b8869e169747bb6eb2e0628e40d1c6",
      "date": "2025-04-04",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "BioInvent_AR_2024_SE_FINAL.pdf",
      "text_chars": 264240,
      "sha256": "01966b16031def74138efc849144ab9f45c904525300f2a9102c2b212247dd63",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 173839
        },
        {
          "number": 2,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 90399
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4e46e0f8f95e50791a1efc8f5291065e",
      "date": "2025-02-27",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "BioInvent_Q4_2024_SE_Final.pdf",
      "text_chars": 63027,
      "sha256": "84f9d860cd29baa7e8faa628a471da8d32e7f31ae82dea8c5b947383677bad6d",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 63027
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a6f0722ec763ee02c5204b7bb5397531e",
      "date": "2024-10-31",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "BioInvent_Q3_2024_SE_Final.pdf",
      "text_chars": 64135,
      "sha256": "240176b82d9e84f7441753a319c02de449d5a7332909d6f0c16bdc5b0dc6d422",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 64135
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a8c9a195497c084357930d08809bd444d",
      "date": "2024-08-29",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "BioInvent_Q2_2024_SE_Final.pdf",
      "text_chars": 65072,
      "sha256": "d87a7337d230474edc9255512d8e54ec176e2ae3b84aa7701ad9a01665f29f65",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 65072
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a02eeedd16b87572fea4fcf26b0036b83",
      "date": "2024-04-24",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "BioInvent_Q1_2024_SE_Final.pdf",
      "text_chars": 57224,
      "sha256": "2330486ede597bccc52644461b86760db9c1fe658e5b7f0be2699431033a1d77",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 57224
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a364100d8e3ca8d4be33a4e4eb14893b9",
      "date": "2024-04-04",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "BioInvent_AR_2023_SE.pdf",
      "text_chars": 253055,
      "sha256": "ed832cbeb1c10ece3a28450f47b49f338d8d1000b6e892991e84f7de368cbd3f",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 178243
        },
        {
          "number": 2,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 74810
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2412234949072bf59eac8ed22b6f1633",
      "date": "2024-02-22",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "BioInvent_Q4_2023_SE_21_Februari.pdf",
      "text_chars": 59858,
      "sha256": "2d189019d4289cc37d2484e846ec7a2e9eb1432009e169b77e34fc954b2566e7",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 59858
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4d494801f274a18bac47cb87692323de",
      "date": "2023-10-26",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "BioInvent_Q3_2023_SE.pdf",
      "text_chars": 55909,
      "sha256": "f088a9b62e0de2fddf99459d82055070e218251219008656016d322dc900782e",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 55909
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2ca36c1ee58d29ec5d20efefaa15b8d0",
      "date": "2023-08-30",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "BioInvent_Q2_2023_SE_Final.pdf",
      "text_chars": 57056,
      "sha256": "266f99d8d9266ae077b85ffdfca158499eff19828176065eb8f8742e17c79dad",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 57056
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/afbe6ff197068f6b7d4cbebf39b901af2",
      "date": "2023-04-26",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "BioInvent_Q1_2023_SE_Final.pdf",
      "text_chars": 53310,
      "sha256": "dd69154f612588fe8b682c646a8b90d596286f7c55ae6eb5c35ca0596f7bdbe9",
      "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 53310
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/bioinvent-international",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 16469,
      "sha256": "5873c73cf7fdf34a23e844d44b138c58d40a938295f60c9ff9c6f8fe40771260",
      "url": "/company/bioinvent-international/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/bioinvent-international/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/bioinvent-international/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 16469
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/bioinvent-international/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/bioinvent-international/market/history.json",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/bioinvent-international/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/bioinvent-international/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/instrument.json"
    },
    {
      "label": "SEC sammanfattning JSON",
      "url": "/company/bioinvent-international/market/sec-summary.json",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/sec-summary.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/bioinvent-international/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/bioinvent-international/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/bioinvent-international/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": true,
    "status": "retrieved",
    "captured_at": "2026-08-02T19:22:48Z",
    "view_count": 4,
    "url": "/company/bioinvent-international/morningstar",
    "path": "D:\\Web\\aktieanalys\\public\\company\\.bioinvent-international.tmp\\morningstar",
    "files": [
      "index.html",
      "summary.txt",
      "screenshot.png"
    ]
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/bioinvent-international/finansinspektionen",
    "transaction_count": 2,
    "aggregate_short_percent": 0.4,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/bioinvent-international/llms.txt",
  "json_url": "/company/bioinvent-international/company.json",
  "document_index_url": "/company/bioinvent-international/documents.json",
  "absolute_url": "https://spela.port0.org/company/bioinvent-international"
}